A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer.
about
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A clinically relevant decrease ...... nt metastatic prostate cancer.
@en
A clinically relevant decrease ...... nt metastatic prostate cancer.
@nl
type
label
A clinically relevant decrease ...... nt metastatic prostate cancer.
@en
A clinically relevant decrease ...... nt metastatic prostate cancer.
@nl
prefLabel
A clinically relevant decrease ...... nt metastatic prostate cancer.
@en
A clinically relevant decrease ...... nt metastatic prostate cancer.
@nl
P2860
P50
P356
P1476
A clinically relevant decrease ...... nt metastatic prostate cancer.
@en
P2093
Nielka P van Erp
P2860
P304
P356
10.1111/BCP.13532
P407
P577
2018-01-31T00:00:00Z